Clinical Trial Update: Systemic Inflammatory Markers in B-cell Neoplasm

View source ↗

Summary

A not-yet-recruiting clinical trial at Assiut University is investigating systemic inflammatory markers in patients with B-cell neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Neoplasm

Snippet

Sponsor: Assiut University | Conditions: B-cell Neoplasm | Status: NOT_YET_RECRUITING